| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Maheswari Senthil | Q96341637 |
| Nathan R. Wall | Q38324556 | ||
| P2093 | author name string | Maheswari Senthil | |
| Matthew Selleck | |||
| James R W McMullen | |||
| P2860 | cites work | Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer | Q24556616 |
| Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers | Q24614672 | ||
| Circulating microRNAs as stable blood-based markers for cancer detection | Q24652098 | ||
| Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy | Q26768402 | ||
| Potential Role of Circulating MiR-21 in the Diagnosis and Prognosis of Digestive System Cancer: A Systematic Review and Meta-Analysis | Q26774763 | ||
| Unique microRNA molecular profiles in lung cancer diagnosis and prognosis | Q27860631 | ||
| Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells | Q27860960 | ||
| MicroRNA expression profiles classify human cancers | Q28032481 | ||
| Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases | Q28131780 | ||
| Cancer statistics, 2016 | Q29547383 | ||
| Exosomal microRNA: a diagnostic marker for lung cancer | Q29614235 | ||
| MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer | Q29614237 | ||
| Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET | Q29618139 | ||
| Functional delivery of viral miRNAs via exosomes | Q29619574 | ||
| Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients | Q33559632 | ||
| Successful management of microscopic residual disease in large bowel cancer | Q33651971 | ||
| miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase | Q33695070 | ||
| Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases. | Q34005870 | ||
| The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma | Q34209973 | ||
| Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer | Q34455096 | ||
| Adjuvant hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with colon cancer at high risk of peritoneal carcinomatosis; the COLOPEC randomized multicentre trial | Q34477640 | ||
| Microfluidic-based multiplex qRT-PCR identifies diagnostic and prognostic microRNA signatures in the sera of prostate cancer patients | Q34496664 | ||
| Early diagnostic value of survivin and its alternative splice variants in breast cancer | Q35118374 | ||
| Long-term survival of peritoneal carcinomatosis of colorectal origin | Q81645274 | ||
| Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis | Q82810703 | ||
| Usefulness of endoscopic ultrasonography in preoperative gastric cancer staging: diagnostic yield and therapeutic impact | Q84551853 | ||
| Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study | Q84791504 | ||
| Comparison of MRI and CT for predicting the Peritoneal Cancer Index (PCI) preoperatively in patients being considered for cytoreductive surgical procedures | Q85275150 | ||
| MicroRNA expression patterns associated with hyperfunctioning and non-hyperfunctioning phenotypes in adrenocortical adenomas | Q87135526 | ||
| Differential blood-based diagnosis between benign prostatic hyperplasia and prostate cancer: miRNA as source for biomarkers independent of PSA level, Gleason score, or TNM status | Q87200433 | ||
| Malignant effusions and immunogenic tumour-derived exosomes | Q44082514 | ||
| Stability of endogenous and added RNA in blood specimens, serum, and plasma | Q44153103 | ||
| Clinical Value of (18)F-FDG- PET-CT in the Preoperative Staging of Peritoneal Carcinomatosis from Colorectal Origin | Q49039015 | ||
| A prospective study evaluating diffusion weighted magnetic resonance imaging (DW-MRI) in the detection of peritoneal carcinomatosis in suspected gynecologic malignancies. | Q53117341 | ||
| Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility? | Q53213677 | ||
| Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: A multi‐institutional study | Q53264117 | ||
| Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT. | Q53472724 | ||
| Transvaginal sonographic features of peritoneal carcinomatosis | Q56999369 | ||
| Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study | Q73368601 | ||
| Peritoneal tumor: MR imaging with dilute oral barium and intravenous gadolinium-containing contrast agents compared with unenhanced MR imaging and CT | Q73551473 | ||
| Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer | Q79150738 | ||
| Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer | Q79372207 | ||
| Survivin is released from cancer cells via exosomes. | Q35217196 | ||
| CT, MRI and PET imaging in peritoneal malignancy | Q35495958 | ||
| MicroRNA-320c inhibits tumorous behaviors of bladder cancer by targeting Cyclin-dependent kinase 6 | Q35605883 | ||
| Exosomal miRNAs from Peritoneum Lavage Fluid as Potential Prognostic Biomarkers of Peritoneal Metastasis in Gastric Cancer | Q35712145 | ||
| Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. | Q35721069 | ||
| The emerging role of exosomes in survivin secretion | Q35810533 | ||
| Identification of a blood-borne miRNA signature of synovial sarcoma | Q35927721 | ||
| Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts | Q36028740 | ||
| Proteomic Profiling of Serum-Derived Exosomes from Ethnically Diverse Prostate Cancer Patients | Q36520462 | ||
| Complex patterns of altered MicroRNA expression during the adenoma-adenocarcinoma sequence for microsatellite-stable colorectal cancer | Q36529740 | ||
| Tumour exosome integrins determine organotropic metastasis. | Q36677568 | ||
| MicroRNA-1225-5p inhibits proliferation and metastasis of gastric carcinoma through repressing insulin receptor substrate-1 and activation of β-catenin signaling | Q36782537 | ||
| microRNA expression profiling on individual breast cancer patients identifies novel panel of circulating microRNA for early detection. | Q36902655 | ||
| Role of cancer stem cells in racial disparity in colorectal cancer. | Q37045590 | ||
| The eligibility for local-regional treatment of peritoneal surface malignancy. | Q37251994 | ||
| The Fifth International Workshop on Peritoneal Surface Malignancy (Milan, Italy, December 4-6, 2006): methodology of disease-specific consensus. | Q37252027 | ||
| Significance of serum tumor marker levels in peritoneal carcinomatosis of appendiceal origin | Q37267412 | ||
| Secondary tumors and tumorlike lesions of the peritoneal cavity: imaging features with pathologic correlation | Q37424599 | ||
| Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. | Q37669854 | ||
| A pharmacological review on intraperitoneal chemotherapy for peritoneal malignancy | Q37821289 | ||
| Colorectal cancer diagnostics: biomarkers, cell-free DNA, circulating tumor cells and defining heterogeneous populations by single-cell analysis | Q38124901 | ||
| Peritoneal cancer treatment | Q38195114 | ||
| MicroRNA-1207-5p inhibits hepatocellular carcinoma cell growth and invasion through the fatty acid synthase-mediated Akt/mTOR signalling pathway | Q38755524 | ||
| MicroRNA-320 was downregulated in non-small cell lung cancer and inhibited cell proliferation, migration and invasion by targeting fatty acid synthase | Q38765838 | ||
| Characterization of uptake and internalization of exosomes by bladder cancer cells. | Q39020404 | ||
| MiR-20b, -21, and -130b inhibit PTEN expression resulting in B7-H1 over-expression in advanced colorectal cancer | Q39030067 | ||
| Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment | Q39536084 | ||
| Comparison between the gastric cancer cell line MKN-45 and the high-potential peritoneal dissemination gastric cancer cell line MKN-45P. | Q39614348 | ||
| Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential | Q39871645 | ||
| Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study | Q41595425 | ||
| The correlation between miRNA and lymph node metastasis in gastric cancer | Q41911966 | ||
| Peritoneal carcinomatosis of colorectal origin: Incidence, prognosis and treatment options. | Q42398293 | ||
| Progress in the combined modality management of peritoneal carcinomatosis | Q43505165 | ||
| Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. | Q43932503 | ||
| Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI. | Q44076876 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 26 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | peritoneal carcinomatosis | Q2071182 |
| peritoneal neoplasm | Q19000425 | ||
| liquid biopsy | Q22349364 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 43481-43490 | |
| P577 | publication date | 2017-06-01 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy | |
| P478 | volume | 8 |
| Q92711624 | A Case of Advanced Gastric Cancer with Peritoneal Metastasis Treated Successfully with Nivolumab |
| Q64233859 | Clinical value of combined detection of miR-1202 and miR-195 in early diagnosis of cervical cancer |
| Q89734122 | Efficacy of ascitic fluid cell block for diagnosing primary ovarian, peritoneal, and tubal cancer in patients with peritoneal carcinomatosis with ascites |
| Q88722639 | Exosome-mediated peritoneal dissemination in gastric cancer and its clinical applications |
| Q89471694 | Influence of peritoneal carcinomatosis on perioperative outcome in palliative gastric bypass for malignant gastric outlet obstruction - a retrospective cohort study |
| Q55508871 | Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with 64Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts. |
| Q90731964 | Overall clinical and trichoscopic analysis performed in patients who underwent pressurized intraperitoneal aerosol chemotherapy (PIPAC) treatment for peritoneal carcinomatosis - initial trial preliminary report |
| Q88262048 | PIPAC puts pressure on peritoneal metastases from pancreatic cancer |
| Q89285313 | Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival |
| Q91828311 | Review of the Application of Nanovesicles and the Human Interstitial Fluid in Gastrointestinal Premalignant Lesion Detection, Diagnosis, Prognosis and Therapy |
| Q57162967 | [Surgical treatment of peritoneal metastases of colorectal cancer] |
Search more.